, a top Democrat on the House Judiciary subcommittee on antitrust has his sights set on a new industry: Big Pharma.
He made the request in a letter sent Monday to committee Chairman Jerrold Nadler, D-N.Y. and subcommittee Chairman David Cicilline, D-R.I., and shared exclusively with CNBC. From there, Neguse told CNBC, the committee could determine if a full investigation is warranted. Neguse wants the committee to examine the Federal Trade Commission's common approach of requiring pharmaceutical companies to divest assets before approving mergers. The two Democratic commissioners at the agency have harshly criticized its historic approach to these mergers and pushed for more thorough reviews.
Neguse wrote in his letter that these deals could have a harmful impact on consumer prices, which can sometimes be a sign of an antitrust violation.decreased drug prices for consumers. However, there is growing consensus that increases in drug prices can be attributed, in part, to mergers and consolidation in the industry," Neguse wrote, citing athat found that less competition was associated with higher generic drug prices.
Danish Mask Study in Annals of Internal Medicine. A 4800 person randomized trial. Almost identical results: 42 of 2393 people(1.8%) in the mask group & 53 of 2470(2.1%) in no-mask group infected with C19 - The other side of the pandemic the MSM & leftists don’t want you to know.
I democrats siete morti
Finished the tech probe? You mean find out tech is wildly out of control and then do nothing? TIME TO MOVE ON. LOL
Yep, they’re in the process of bailing out every other industry right now so now seems like a great opportunity to go after them!
🤣🤣🤣. Good one
Can we stop with all these investigations and start actually doing something for the country like working on infrastructure?
good luck
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.